{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:57:34Z","timestamp":1792195054888,"version":"4.4.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Biocodex Microbiota Foundation Grant"},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01 AA24726"],"award-info":[{"award-number":["R01 AA24726"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA020703"],"award-info":[{"award-number":["R01AA020703"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["U01 AA026939"],"award-info":[{"award-number":["U01 AA026939"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["P50 AA011999"],"award-info":[{"award-number":["P50 AA011999"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","award":["BX004594"],"award-info":[{"award-number":["BX004594"]}],"id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK120515"],"award-info":[{"award-number":["P30 DK120515"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fond National de Recherche Scientifique Belgium","award":["J.0146.17"],"award-info":[{"award-number":["J.0146.17"]}]},{"name":"Fond National de Recherche Scientifique Belgium","award":["T.0217.18"],"award-info":[{"award-number":["T.0217.18"]}]},{"name":"Action de Recherche Concert\u00e9e, Universit\u00e9 Catholique de Louvain"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The human gut microbiome (bacteria, fungi, viruses, and archaea) is a complex and diverse ecosystem. It plays an important role in human health, but is involved in several intestinal and extraintestinal diseases. Most research to date has focused on the role of bacteria, while studies focusing on fungi (also referred to as \u201cmycobiome\u201d or \u201cfungome\u201d) are still in its infancy. In this review, we focus on the existing literature available about the gut mycobiome with an emphasis on compositional mycobiome changes associated with liver diseases, the impact on pathogenesis of disease, and its potential use as therapeutic targets. We also provide insights into current methodologies of studying mycobiome, and we highlight the interkingdom interactions in the context of disease and how they affect health of the host. Herein, by focusing on the gut mycobiome, this review provides novel insights and directions for liver research.<\/jats:p>","DOI":"10.1007\/s00535-020-01740-5","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T16:02:51Z","timestamp":1604592171000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The gut mycobiome: a novel player in chronic liver diseases"],"prefix":"10.1007","volume":"56","author":[{"given":"Lu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"St\u00e4rkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Gao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick Eugene","family":"Fouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Bacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schnabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"1740_CR1","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cell.2012.01.035","volume":"148","author":"JC Clemente","year":"2012","unstructured":"Clemente JC, Ursell LK, Parfrey LW, et al. The impact of the gut microbiota on human health: an integrative view. Cell. 2012;148:1258\u201370.","journal-title":"Cell"},{"key":"1740_CR2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/femsre\/fuw047","volume":"41","author":"CE Huseyin","year":"2017","unstructured":"Huseyin CE, O\u2019Toole PW, Cotter PD, et al. Forgotten fungi-the gut mycobiome in human health and disease. FEMS Microbiol Rev. 2017;41:479\u2013511.","journal-title":"FEMS Microbiol Rev"},{"key":"1740_CR3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","volume":"9","author":"JL Round","year":"2009","unstructured":"Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9:313\u201323.","journal-title":"Nat Rev Immunol"},{"key":"1740_CR4","doi-asserted-by":"crossref","first-page":"e1438","DOI":"10.1002\/wsbm.1438","volume":"11","author":"GC Lai","year":"2019","unstructured":"Lai GC, Tan TG, Pavelka N. The mammalian mycobiome: a complex system in a dynamic relationship with the host. Wiley Interdiscip Rev Syst Biol Med. 2019;11:e1438.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"1740_CR5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.chom.2017.11.013","volume":"22","author":"N Hern\u00e1ndez-Santos","year":"2017","unstructured":"Hern\u00e1ndez-Santos N, Klein BS. Through the scope darkly: the gut mycobiome comes into focus. Cell Host Microbe. 2017;22:728\u20139.","journal-title":"Cell Host Microbe"},{"key":"1740_CR6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59\u201365.","journal-title":"Nature"},{"key":"1740_CR7","first-page":"331","volume":"16","author":"ML Richard","year":"2019","unstructured":"Richard ML, Sokol H. The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases. Nat Rev Gastroenterol Hepatol. 2019;16:331\u201345.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1740_CR8","doi-asserted-by":"crossref","first-page":"a019810","DOI":"10.1101\/cshperspect.a019810","volume":"5","author":"PC Seed","year":"2014","unstructured":"Seed PC. The human mycobiome. Cold Spring Harb Perspect Med. 2014;5:a019810.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1740_CR9","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1126\/science.289.5486.1920","volume":"289","author":"D Redecker","year":"2000","unstructured":"Redecker D, Kodner R, Graham LE. Glomalean fungi from the Ordovician. Science. 2000;289:1920\u20131.","journal-title":"Science"},{"key":"1740_CR10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3732\/ajb.1000298","volume":"98","author":"M Blackwell","year":"2011","unstructured":"Blackwell M. The fungi: 1, 2, 3\u2026 5.1 million species? Am J Bot. 2011;98:426\u201338.","journal-title":"Am J Bot"},{"key":"1740_CR11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/MR.59.4.686-698.1995","volume":"59","author":"ME Zolan","year":"1995","unstructured":"Zolan ME. Chromosome-length polymorphism in fungi. Microbiol Rev. 1995;59:686\u201398.","journal-title":"Microbiol Rev"},{"key":"1740_CR12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40168-017-0373-4","volume":"5","author":"AK Nash","year":"2017","unstructured":"Nash AK, Auchtung TA, Wong MC, et al. The gut mycobiome of the human microbiome project healthy cohort. Microbiome. 2017;5:153.","journal-title":"Microbiome"},{"key":"1740_CR13","doi-asserted-by":"crossref","first-page":"e90899","DOI":"10.1371\/journal.pone.0090899","volume":"9","author":"AK Dupuy","year":"2014","unstructured":"Dupuy AK, David MS, Li L, et al. Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal. PLoS ONE. 2014;9:e90899.","journal-title":"PLoS ONE"},{"key":"1740_CR14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1348-0421.2011.00364.x","volume":"55","author":"E Zhang","year":"2011","unstructured":"Zhang E, Tanaka T, Tajima M, et al. Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects. Microbiol Immunol. 2011;55:625\u201332.","journal-title":"Microbiol Immunol"},{"key":"1740_CR15","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3389\/fmicb.2017.01432","volume":"8","author":"CE Huseyin","year":"2017","unstructured":"Huseyin CE, Rubio RC, O\u2019Sullivan O, et al. The fungal frontier: a comparative analysis of methods used in the study of the human gut mycobiome. Front Microbiol. 2017;8:1432.","journal-title":"Front Microbiol"},{"key":"1740_CR16","first-page":"89","volume":"6","author":"LD Nguyen","year":"2015","unstructured":"Nguyen LD, Viscogliosi E, Delhaes L. The lung mycobiome: an emerging field of the human respiratory microbiome. Front Microbiol. 2015;6:89.","journal-title":"Front Microbiol"},{"key":"1740_CR17","doi-asserted-by":"crossref","first-page":"e1000713","DOI":"10.1371\/journal.ppat.1000713","volume":"6","author":"MA Ghannoum","year":"2010","unstructured":"Ghannoum MA, Jurevic RJ, Mukherjee PK, et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010;6:e1000713.","journal-title":"PLoS Pathog"},{"key":"1740_CR18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12866-017-1064-9","volume":"17","author":"BA Peters","year":"2017","unstructured":"Peters BA, Wu J, Hayes RB, et al. The oral fungal mycobiome: characteristics and relation to periodontitis in a pilot study. BMC Microbiol. 2017;17:157.","journal-title":"BMC Microbiol"},{"key":"1740_CR19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1067\/mai.2002.128674","volume":"110","author":"HA Burge","year":"2002","unstructured":"Burge HA. An update on pollen and fungal spore aerobiology. J Allergy Clin Immunol. 2002;110:544\u201352.","journal-title":"J Allergy Clin Immunol"},{"key":"1740_CR20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/rccm.201204-0693OC","volume":"186","author":"ES Charlson","year":"2012","unstructured":"Charlson ES, Diamond JM, Bittinger K, et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am J Respir Crit Care Med. 2012;186:536\u201345.","journal-title":"Am J Respir Crit Care Med"},{"key":"1740_CR21","doi-asserted-by":"crossref","first-page":"e66019","DOI":"10.1371\/journal.pone.0066019","volume":"8","author":"C Hoffmann","year":"2013","unstructured":"Hoffmann C, Dollive S, Grunberg S, et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS ONE. 2013;8:e66019.","journal-title":"PLoS ONE"},{"key":"1740_CR22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/CMR.00021-11","volume":"25","author":"G Gaitanis","year":"2012","unstructured":"Gaitanis G, Magiatis P, Hantschke M, et al. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012;25:106\u201341.","journal-title":"Clin Microbiol Rev"},{"key":"1740_CR23","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jid.2016.05.130","volume":"136","author":"JH Jo","year":"2016","unstructured":"Jo JH, Deming C, Kennedy EA, et al. Diverse human skin fungal communities in children converge in adulthood. J Invest Dermatol. 2016;136:2356\u201363.","journal-title":"J Invest Dermatol"},{"issue":"Suppl 4","key":"1740_CR24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","volume":"51","author":"B Havlickova","year":"2008","unstructured":"Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51(Suppl 4):2\u201315.","journal-title":"Mycoses"},{"issue":"165","key":"1740_CR25","doi-asserted-by":"crossref","first-page":"rv13","DOI":"10.1126\/scitranslmed.3004404","volume":"4","author":"GD Brown","year":"2012","unstructured":"Brown GD, Denning DW, Gow NA, et al. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):rv13.","journal-title":"Sci Transl Med"},{"key":"1740_CR26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.immuni.2019.05.023","volume":"50","author":"XV Li","year":"2019","unstructured":"Li XV, Leonardi I, Iliev ID. Gut mycobiota in immunity and inflammatory disease. Immunity. 2019;50:1365\u201379.","journal-title":"Immunity"},{"issue":"1340\u201355","key":"1740_CR27","first-page":"e15","volume":"176","author":"P Bacher","year":"2019","unstructured":"Bacher P, Hohnstein T, Beerbaum E, et al. Human anti-fungal Th17 Immunity and pathology rely on cross-reactivity against candida albicans. Cell. 2019;176(1340\u201355):e15.","journal-title":"Cell"},{"issue":"389\u2013403","key":"1740_CR28","first-page":"e6","volume":"25","author":"F Sparber","year":"2019","unstructured":"Sparber F, De Gregorio C, Steckholzer S, et al. the skin commensal yeast malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation. Cell Host Microbe. 2019;25(389\u2013403):e6.","journal-title":"Cell Host Microbe"},{"key":"1740_CR29","first-page":"261","volume":"35","author":"L Jiang","year":"2020","unstructured":"Jiang L, Schnabl B. Gut microbiota in liver disease: what do we know and what do we not know? Physiol (Bethesda). 2020;35:261\u201374.","journal-title":"Physiol (Bethesda)"},{"key":"1740_CR30","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-16-2929","volume":"77","author":"S Thomas","year":"2017","unstructured":"Thomas S, Izard J, Walsh E, et al. The host microbiome regulates and maintains human health: a primer and perspective for non-microbiologists. Cancer Res. 2017;77:1783\u2013812.","journal-title":"Cancer Res"},{"key":"1740_CR31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature23292","volume":"548","author":"KR Foster","year":"2017","unstructured":"Foster KR, Schluter J, Coyte KZ, et al. The evolution of the host microbiome as an ecosystem on a leash. Nature. 2017;548:43\u201351.","journal-title":"Nature"},{"key":"1740_CR32","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.3389\/fmicb.2018.03249","volume":"9","author":"JD Forbes","year":"2018","unstructured":"Forbes JD, Bernstein CN, Tremlett H, et al. A fungal world: could the gut mycobiome be involved in neurological disease? Front Microbiol. 2018;9:3249.","journal-title":"Front Microbiol"},{"key":"1740_CR33","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nri.2017.55","volume":"17","author":"ID Iliev","year":"2017","unstructured":"Iliev ID, Leonardi I. Fungal dysbiosis: immunity and interactions at mucosal barriers. Nat Rev Immunol. 2017;17:635\u201346.","journal-title":"Nat Rev Immunol"},{"key":"1740_CR34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12281-010-0034-6","volume":"4","author":"FL van de Veerdonk","year":"2010","unstructured":"van de Veerdonk FL, Netea MG. T-cell subsets and antifungal host defenses. Curr Fungal Infect Rep. 2010;4:238\u201343.","journal-title":"Curr Fungal Infect Rep"},{"key":"1740_CR35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mib.2020.06.006","volume":"56","author":"A Scheffold","year":"2020","unstructured":"Scheffold A, Bacher P. Anti-fungal T cell responses in the lung and modulation by the gut-lung axis. Curr Opin Microbiol. 2020;56:67\u201373.","journal-title":"Curr Opin Microbiol"},{"key":"1740_CR36","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S1473-3099(11)70217-1","volume":"11","author":"DC Vinh","year":"2011","unstructured":"Vinh DC. Insights into human antifungal immunity from primary immunodeficiencies. Lancet Infect Dis. 2011;11:780\u201392.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1740_CR37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/jof3040052","volume":"3","author":"BG Mengesha","year":"2017","unstructured":"Mengesha BG, Conti HR. The role of IL-17 in protection against mucosal candida infections. J Fungi (Basel). 2017;3(4):52.","journal-title":"J Fungi (Basel)."},{"key":"1740_CR38","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/mi.2017.97","volume":"11","author":"J Li","year":"2018","unstructured":"Li J, Casanova JL, Puel A. Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation. Mucosal Immunol. 2018;11:581\u20139.","journal-title":"Mucosal Immunol"},{"key":"1740_CR39","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s10875-018-0539-2","volume":"38","author":"E Corvilain","year":"2018","unstructured":"Corvilain E, Casanova JL, Puel A. Inherited CARD9 deficiency: invasive disease caused by ascomycete fungi in previously healthy children and adults. J Clin Immunol. 2018;38:656\u201393.","journal-title":"J Clin Immunol"},{"key":"1740_CR40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cell.2015.08.058","volume":"163","author":"K Atarashi","year":"2015","unstructured":"Atarashi K, Tanoue T, Ando M, et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell. 2015;163:367\u201380.","journal-title":"Cell"},{"key":"1740_CR41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007;8:639\u201346.","journal-title":"Nat Immunol"},{"issue":"404\u201317","key":"1740_CR42","first-page":"e6","volume":"25","author":"TY Shao","year":"2019","unstructured":"Shao TY, Ang WXG, Jiang TT, et al. Commensal candida albicans positively calibrates systemic Th17 immunological responses. Cell Host Microbe. 2019;25(404\u201317):e6.","journal-title":"Cell Host Microbe"},{"issue":"1067\u201378","key":"1740_CR43","first-page":"e16","volume":"167","author":"P Bacher","year":"2016","unstructured":"Bacher P, Heinrich F, Stervbo U, et al. Regulatory T cell specificity directs tolerance versus allergy against aeroantigens in humans. Cell. 2016;167(1067\u201378):e16.","journal-title":"Cell"},{"key":"1740_CR44","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.4049\/jimmunol.0902972","volume":"184","author":"L Rizzetto","year":"2010","unstructured":"Rizzetto L, Kuka M, De Filippo C, et al. Differential IL-17 production and mannan recognition contribute to fungal pathogenicity and commensalism. J Immunol. 2010;184:4258\u201368.","journal-title":"J Immunol"},{"key":"1740_CR45","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","volume":"66","author":"H Sokol","year":"2017","unstructured":"Sokol H, Leducq V, Aschard H, et al. Fungal microbiota dysbiosis in IBD. Gut. 2017;66:1039\u201348.","journal-title":"Gut"},{"key":"1740_CR46","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/ajg.2009.225","volume":"104","author":"A Standaert-Vitse","year":"2009","unstructured":"Standaert-Vitse A, Sendid B, Joossens M, et al. Candida albicans colonization and ASCA in familial Crohn\u2019s disease. Am J Gastroenterol. 2009;104:1745\u201353.","journal-title":"Am J Gastroenterol"},{"issue":"377\u201388","key":"1740_CR47","first-page":"e6","volume":"25","author":"JJ Limon","year":"2019","unstructured":"Limon JJ, Tang J, Li D, et al. Malassezia is associated with Crohn\u2019s disease and exacerbates colitis in mouse models. Cell Host Microbe. 2019;25(377\u201388):e6.","journal-title":"Cell Host Microbe"},{"key":"1740_CR48","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30832","volume":"71","author":"S Lang","year":"2020","unstructured":"Lang S, Duan Y, Liu J, et al. Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis. Hepatology. 2020;71:522\u201338.","journal-title":"Hepatology"},{"key":"1740_CR49","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI90562","volume":"127","author":"AM Yang","year":"2017","unstructured":"Yang AM, Inamine T, Hochrath K, et al. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest. 2017;127:2829\u201341.","journal-title":"J Clin Invest"},{"key":"1740_CR50","doi-asserted-by":"crossref","first-page":"14600","DOI":"10.1038\/srep14600","volume":"5","author":"M Mar Rodriguez","year":"2015","unstructured":"Mar Rodriguez M, Perez D, Javier Chaves F, et al. Obesity changes the human gut mycobiome. Sci Rep. 2015;5:14600.","journal-title":"Sci Rep"},{"key":"1740_CR51","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/gutjnl-2016-313170","volume":"67","author":"JS Bajaj","year":"2018","unstructured":"Bajaj JS, Liu EJ, Kheradman R, et al. Fungal dysbiosis in cirrhosis. Gut. 2018;67:1146\u201354.","journal-title":"Gut"},{"key":"1740_CR52","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.chom.2016.05.003","volume":"19","author":"ML Wheeler","year":"2016","unstructured":"Wheeler ML, Limon JJ, Bar AS, et al. Immunological consequences of intestinal fungal dysbiosis. Cell Host Microbe. 2016;19:865\u201373.","journal-title":"Cell Host Microbe"},{"key":"1740_CR53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40168-018-0538-9","volume":"6","author":"B Sovran","year":"2018","unstructured":"Sovran B, Planchais J, Jegou S, et al. Enterobacteriaceae are essential for the modulation of colitis severity by fungi. Microbiome. 2018;6:152.","journal-title":"Microbiome"},{"key":"1740_CR54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, et al. Host\u2013microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119\u201324.","journal-title":"Nature"},{"key":"1740_CR55","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2006.02.009","volume":"130","author":"A Standaert-Vitse","year":"2006","unstructured":"Standaert-Vitse A, Jouault T, Vandewalle P, et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn\u2019s disease. Gastroenterology. 2006;130:1764\u201375.","journal-title":"Gastroenterology"},{"key":"1740_CR56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.1501175","volume":"196","author":"M Rau","year":"2016","unstructured":"Rau M, Schilling AK, Meertens J, et al. Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory T cell ratio in peripheral blood and in the liver. J Immunol. 2016;196:97\u2013105.","journal-title":"J Immunol"},{"key":"1740_CR57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","volume":"30","author":"AL Gomes","year":"2016","unstructured":"Gomes AL, Teijeiro A, Buren S, et al. Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma. Cancer Cell. 2016;30:161\u201375.","journal-title":"Cancer Cell"},{"key":"1740_CR58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.15403\/jgld.2014.1121.263.pak","volume":"26","author":"A Parfieniuk-Kowerda","year":"2017","unstructured":"Parfieniuk-Kowerda A, Swiderska M, Szulzyk T, et al. Serum concentrations of Th17-associated interleukins and autoimmune phenomena are associated with the degree of liver damage in alcoholic liver disease. J Gastrointestin Liver Dis. 2017;26:269\u201374.","journal-title":"J Gastrointestin Liver Dis"},{"key":"1740_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31321","author":"S Chu","year":"2020","unstructured":"Chu S, Sun R, Gu X, et al. Inhibition of sphingosine-1-phosphate-induced Th17 cells ameliorates alcoholic steatohepatitis in mice. Hepatology. 2020;. https:\/\/doi.org\/10.1002\/hep.31321.","journal-title":"Hepatology."},{"issue":"380","key":"1740_CR60","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf9044","volume":"9","author":"TR Chiaro","year":"2017","unstructured":"Chiaro TR, Soto R, Zac Stephens W, et al. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Sci Transl Med. 2017;9(380):eaaf9044.","journal-title":"Sci Transl Med."},{"key":"1740_CR61","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3389\/fimmu.2017.01614","volume":"8","author":"F Sparber","year":"2017","unstructured":"Sparber F, LeibundGut-Landmann S. Host responses to Malassezia spp. in the mammalian skin. Front Immunol. 2017;8:1614.","journal-title":"Front Immunol"},{"key":"1740_CR62","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mehy.2018.05.001","volume":"116","author":"M Napolitano","year":"2018","unstructured":"Napolitano M, Patruno C. Aryl hydrocarbon receptor (AhR) a possible target for the treatment of skin disease. Med Hypotheses. 2018;116:96\u2013100.","journal-title":"Med Hypotheses"},{"key":"1740_CR63","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1128\/JCM.34.6.1583-1585.1996","volume":"34","author":"AJ Morris","year":"1996","unstructured":"Morris AJ, Byrne TC, Madden JF, et al. Duration of incubation of fungal cultures. J Clin Microbiol. 1996;34:1583\u20135.","journal-title":"J Clin Microbiol"},{"key":"1740_CR64","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/ismej.2008.76","volume":"2","author":"PD Scanlan","year":"2008","unstructured":"Scanlan PD, Marchesi JR. Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces. ISME J. 2008;2:1183\u201393.","journal-title":"ISME J"},{"key":"1740_CR65","doi-asserted-by":"crossref","first-page":"e40888","DOI":"10.1371\/journal.pone.0040888","volume":"7","author":"I Hamad","year":"2012","unstructured":"Hamad I, Sokhna C, Raoult D, et al. Molecular detection of eukaryotes in a single human stool sample from Senegal. PLoS ONE. 2012;7:e40888.","journal-title":"PLoS ONE"},{"key":"1740_CR66","doi-asserted-by":"crossref","first-page":"e59474","DOI":"10.1371\/journal.pone.0059474","volume":"8","author":"N Gouba","year":"2013","unstructured":"Gouba N, Raoult D, Drancourt M. Plant and fungal diversity in gut microbiota as revealed by molecular and culture investigations. PLoS ONE. 2013;8:e59474.","journal-title":"PLoS ONE"},{"key":"1740_CR67","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jhep.2019.09.029","volume":"72","author":"H Chu","year":"2020","unstructured":"Chu H, Duan Y, Lang S, et al. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease. J Hepatol. 2020;72:391\u2013400.","journal-title":"J Hepatol"},{"key":"1740_CR68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/JCM.34.1.58-61.1996","volume":"34","author":"MA Pfaller","year":"1996","unstructured":"Pfaller MA, Houston A, Coffmann S. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol. 1996;34:58\u201361.","journal-title":"J Clin Microbiol"},{"key":"1740_CR69","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/13693780500130564","volume":"43","author":"T Kaneko","year":"2005","unstructured":"Kaneko T, Makimura K, Onozaki M, et al. Vital growth factors of Malassezia species on modified CHROMagar Candida. Med Mycol. 2005;43:699\u2013704.","journal-title":"Med Mycol"},{"key":"1740_CR70","doi-asserted-by":"crossref","first-page":"16788","DOI":"10.1038\/s41598-017-17132-4","volume":"7","author":"I Hamad","year":"2017","unstructured":"Hamad I, Ranque S, Azhar EI, et al. Culturomics and amplicon-based metagenomic approaches for the study of fungal population in human gut microbiota. Sci Rep. 2017;7:16788.","journal-title":"Sci Rep"},{"key":"1740_CR71","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1462-2920.2004.00675.x","volume":"6","author":"IC Anderson","year":"2004","unstructured":"Anderson IC, Cairney JW. Diversity and ecology of soil fungal communities: increased understanding through the application of molecular techniques. Environ Microbiol. 2004;6:769\u201379.","journal-title":"Environ Microbiol"},{"key":"1740_CR72","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/mmy.40.1.87.109","volume":"40","author":"PC Iwen","year":"2002","unstructured":"Iwen PC, Hinrichs SH, Rupp ME. Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Med Mycol. 2002;40:87\u2013109.","journal-title":"Med Mycol"},{"key":"1740_CR73","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1073\/pnas.1117018109","volume":"109","author":"CL Schoch","year":"2012","unstructured":"Schoch CL, Seifert KA, Huhndorf S, et al. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc Natl Acad Sci USA. 2012;109:6241\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1740_CR74","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2015.04.004","volume":"421","author":"J Tang","year":"2015","unstructured":"Tang J, Iliev ID, Brown J, et al. Mycobiome: approaches to analysis of intestinal fungi. J Immunol Methods. 2015;421:112\u201321.","journal-title":"J Immunol Methods"},{"key":"1740_CR75","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pone.0000059","volume":"1","author":"RH Nilsson","year":"2006","unstructured":"Nilsson RH, Ryberg M, Kristiansson E, et al. Taxonomic reliability of DNA sequences in public sequence databases: a fungal perspective. PLoS ONE. 2006;1:e59.","journal-title":"PLoS ONE"},{"key":"1740_CR76","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1469-8137.2005.01376.x","volume":"166","author":"U Koljalg","year":"2005","unstructured":"Koljalg U, Larsson KH, Abarenkov K, et al. UNITE: a database providing web-based methods for the molecular identification of ectomycorrhizal fungi. New Phytol. 2005;166:1063\u20138.","journal-title":"New Phytol"},{"key":"1740_CR77","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature12171","volume":"498","author":"K Findley","year":"2013","unstructured":"Findley K, Oh J, Yang J, et al. Topographic diversity of fungal and bacterial communities in human skin. Nature. 2013;498:367\u201370.","journal-title":"Nature"},{"key":"1740_CR78","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bau061","volume":"2014","author":"CL Schoch","year":"2014","unstructured":"Schoch CL, Robbertse B, Robert V, et al. Finding needles in haystacks: linking scientific names, reference specimens and molecular data for fungi. Database (Oxford). 2014;2014:bau061","journal-title":"Database (Oxford)"},{"issue":"Suppl 1","key":"1740_CR79","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0168-8278(12)60005-1","volume":"56","author":"P Mathurin","year":"2012","unstructured":"Mathurin P, Lucey MR. Management of alcoholic hepatitis. J Hepatol. 2012;56(Suppl 1):S39-45.","journal-title":"J Hepatol"},{"key":"1740_CR80","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","volume":"71","author":"DW Crabb","year":"2020","unstructured":"Crabb DW, Im GY, Szabo G, et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases. Hepatology. 2020;71:306\u201333.","journal-title":"Hepatology"},{"key":"1740_CR81","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","volume":"146","author":"B Schnabl","year":"2014","unstructured":"Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146:1513\u201324.","journal-title":"Gastroenterology"},{"key":"1740_CR82","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","volume":"148","author":"G Szabo","year":"2015","unstructured":"Szabo G. Gut-liver axis in alcoholic liver disease. Gastroenterology. 2015;148:30\u20136.","journal-title":"Gastroenterology"},{"key":"1740_CR83","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","volume":"575","author":"Y Duan","year":"2019","unstructured":"Duan Y, Llorente C, Lang S, et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019;575:505\u201311.","journal-title":"Nature."},{"key":"1740_CR84","doi-asserted-by":"crossref","first-page":"e53028","DOI":"10.1371\/journal.pone.0053028","volume":"8","author":"L Bull-Otterson","year":"2013","unstructured":"Bull-Otterson L, Feng W, Kirpich I, et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS ONE. 2013;8:e53028.","journal-title":"PLoS ONE"},{"key":"1740_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31459","author":"L Jiang","year":"2020","unstructured":"Jiang L, Lang S, Duan Y, et al. Intestinal virome in patients with alcoholic hepatitis. Hepatology. 2020. https:\/\/doi.org\/10.1002\/hep.31459.","journal-title":"Hepatology."},{"key":"1740_CR86","doi-asserted-by":"crossref","first-page":"1782157","DOI":"10.1080\/19490976.2020.1782157","volume":"12","author":"L Maccioni","year":"2020","unstructured":"Maccioni L, Gao B, Leclercq S, et al. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans. Gut Microbes. 2020;12:1782157.","journal-title":"Gut Microbes"},{"key":"1740_CR87","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123\u201333.","journal-title":"Hepatology"},{"key":"1740_CR88","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","volume":"1","author":"EM Brunt","year":"2015","unstructured":"Brunt EM, Wong VW, Nobili V, et al. Nonalcoholic fatty liver disease. Nat Rev Dis Primers. 2015;1:15080.","journal-title":"Nat Rev Dis Primers"},{"key":"1740_CR89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2016.0109","volume":"23","author":"S Sookoian","year":"2017","unstructured":"Sookoian S, Pirola CJ. Genetic predisposition in nonalcoholic fatty liver disease. Clin Mol Hepatol. 2017;23:1\u201312.","journal-title":"Clin Mol Hepatol"},{"key":"1740_CR90","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","volume":"13","author":"C Leung","year":"2016","unstructured":"Leung C, Rivera L, Furness JB, et al. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol. 2016;13:412\u201325.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1740_CR91","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","volume":"63","author":"J Boursier","year":"2016","unstructured":"Boursier J, Mueller O, Barret M, et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 2016;63:764\u201375.","journal-title":"Hepatology"},{"key":"1740_CR92","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00351-17","author":"T Heisel","year":"2017","unstructured":"Heisel T, Montassier E, Johnson A, et al. High-fat diet changes fungal microbiomes and interkingdom relationships in the murine gut. mSphere. 2017;. https:\/\/doi.org\/10.1128\/mSphere.00351-17.","journal-title":"mSphere."},{"key":"1740_CR93","doi-asserted-by":"crossref","first-page":"291","DOI":"10.5009\/gnl18579","volume":"14","author":"N You","year":"2020","unstructured":"You N, Zhuo L, Zhou J, et al. the role of intestinal fungi and its metabolites in chronic liver diseases. Gut Liver. 2020;14:291\u20136.","journal-title":"Gut Liver"},{"key":"1740_CR94","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/1756283X11428502","volume":"5","author":"T Kelesidis","year":"2012","unstructured":"Kelesidis T, Pothoulakis C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap Adv Gastroenterol. 2012;5:111\u201325.","journal-title":"Therap Adv Gastroenterol"},{"key":"1740_CR95","doi-asserted-by":"crossref","first-page":"e11011","DOI":"10.1128\/mBio.01011-14","volume":"5","author":"A Everard","year":"2014","unstructured":"Everard A, Matamoros S, Geurts L, et al. Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db\/db mice. mBio. 2014;5:e11011\u20134.","journal-title":"mBio"},{"key":"1740_CR96","first-page":"921","volume":"24","author":"YT Liu","year":"2016","unstructured":"Liu YT, Li YQ. Wang YZ [Protective effect of Saccharomyces boulardii against intestinal mucosal barrier injury in rats with nonalcoholic fatty liver disease]. Zhonghua Gan Zang Bing Za Zhi. 2016;24:921\u20136.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"1740_CR97","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","volume":"69","author":"S Lemoinne","year":"2020","unstructured":"Lemoinne S, Kemgang A, Ben Belkacem K, et al. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Gut. 2020;69:92\u2013102.","journal-title":"Gut"},{"key":"1740_CR98","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","volume":"391","author":"JK Dyson","year":"2018","unstructured":"Dyson JK, Beuers U, Jones DEJ, et al. Primary sclerosing cholangitis. Lancet. 2018;391:2547\u201359.","journal-title":"Lancet"},{"issue":"6","key":"1740_CR99","doi-asserted-by":"crossref","first-page":"814","DOI":"10.14309\/ajg.0000000000000604","volume":"115","author":"A Shah","year":"2020","unstructured":"Shah A, Macdonald GA, Morrison M, et al. Targeting the gut microbiome as a treatment for primary sclerosing cholangitis: a conceptional framework. Off J Am Coll Gastroenterol. 2020;115(6):814\u201322.","journal-title":"Off J Am Coll Gastroenterol."},{"key":"1740_CR100","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3748\/wjg.v25.i6.659","volume":"25","author":"BM Fung","year":"2019","unstructured":"Fung BM, Lindor KD, Tabibian JH. Cancer risk in primary sclerosing cholangitis: epidemiology, prevention, and surveillance strategies. World J Gastroenterol. 2019;25:659\u201371.","journal-title":"World J Gastroenterol"},{"key":"1740_CR101","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3748\/wjg.v26.i21.2768","volume":"26","author":"R Little","year":"2020","unstructured":"Little R, Wine E, Kamath BM, et al. Gut microbiome in primary sclerosing cholangitis: a review. World J Gastroenterol. 2020;26:2768\u201380.","journal-title":"World J Gastroenterol"},{"key":"1740_CR102","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/gutjnl-2016-312354","volume":"67","author":"PJ Trivedi","year":"2018","unstructured":"Trivedi PJ, Tickle J, Vesterhus MN, et al. Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner. Gut. 2018;67:1135\u201345.","journal-title":"Gut"},{"key":"1740_CR103","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/apt.15375","volume":"50","author":"M Ruhlemann","year":"2019","unstructured":"Ruhlemann M, Liwinski T, Heinsen FA, et al. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis. Aliment Pharmacol Ther. 2019;50:580\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"1740_CR104","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1365-2249.2003.02166.x","volume":"132","author":"P Muratori","year":"2003","unstructured":"Muratori P, Muratori L, Guidi M, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol. 2003;132:473\u20136.","journal-title":"Clin Exp Immunol"},{"key":"1740_CR105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","volume":"51","author":"G Rudolph","year":"2009","unstructured":"Rudolph G, Gotthardt D, Kloters-Plachky P, et al. Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol. 2009;51:149\u201355.","journal-title":"J Hepatol"},{"key":"1740_CR106","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1099\/jmm.0.008706-0","volume":"58","author":"E Oztas","year":"2009","unstructured":"Oztas E, Odemis B, Kekilli M, et al. Systemic phaeohyphomycosis resembling primary sclerosing cholangitis caused by Exophiala dermatitidis. J Med Microbiol. 2009;58:1243\u20136.","journal-title":"J Med Microbiol"},{"key":"1740_CR107","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1099\/jmm.0.002188-0","volume":"58","author":"KH Hong","year":"2009","unstructured":"Hong KH, Kim JW, Jang SJ, et al. Liver cirrhosis caused by Exophiala dermatitidis. J Med Microbiol. 2009;58:674\u20137.","journal-title":"J Med Microbiol"},{"key":"1740_CR108","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.2174\/092986711796391679","volume":"18","author":"SA El Bialy","year":"2011","unstructured":"El Bialy SA, El Kader KF, El-Ashmawy MB. Current progress in antifibrotics. Curr Med Chem. 2011;18:3082\u201392.","journal-title":"Curr Med Chem"},{"key":"1740_CR109","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2008-1040319","volume":"28","author":"P Tandon","year":"2008","unstructured":"Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28:26\u201342.","journal-title":"Semin Liver Dis"},{"key":"1740_CR110","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","volume":"54","author":"Y Chen","year":"2011","unstructured":"Chen Y, Yang F, Lu H, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 2011;54:562\u201372.","journal-title":"Hepatology"},{"key":"1740_CR111","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","volume":"513","author":"N Qin","year":"2014","unstructured":"Qin N, Yang F, Li A, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513:59\u201364.","journal-title":"Nature"},{"key":"1740_CR112","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.diagmicrobio.2010.04.005","volume":"70","author":"Y Chen","year":"2011","unstructured":"Chen Y, Chen Z, Guo R, et al. Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection. Diagn Microbiol Infect Dis. 2011;70:492\u20138.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1740_CR113","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/cncr.30237","volume":"122","author":"SP Choo","year":"2016","unstructured":"Choo SP, Tan WL, Goh BKP, et al. Comparison of hepatocellular carcinoma in Eastern versus Western populations. Cancer. 2016;122:3430\u201346.","journal-title":"Cancer"},{"key":"1740_CR114","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","volume":"68","author":"Z Ren","year":"2019","unstructured":"Ren Z, Li A, Jiang J, et al. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 2019;68:1014.","journal-title":"Gut"},{"key":"1740_CR115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","volume":"69","author":"FR Ponziani","year":"2019","unstructured":"Ponziani FR, Bhoori S, Castelli C, et al. Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. Hepatology. 2019;69:107\u201320.","journal-title":"Hepatology"},{"key":"1740_CR116","first-page":"305","volume":"22","author":"MC Kew","year":"2013","unstructured":"Kew MC. Aflatoxins as a cause of hepatocellular carcinoma. J Gastrointestin Liver Dis. 2013;22:305\u201310.","journal-title":"J Gastrointestin Liver Dis"},{"key":"1740_CR117","first-page":"313","volume":"62","author":"C Lopez","year":"2002","unstructured":"Lopez C, Ramos L, Bulacio L, et al. Aflatoxin B1 content in patients with hepatic diseases. Med (B Aires). 2002;62:313\u20136.","journal-title":"Med (B Aires)"},{"key":"1740_CR118","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3892\/ol.2013.1169","volume":"5","author":"AS Hamid","year":"2013","unstructured":"Hamid AS, Tesfamariam IG, Zhang Y, et al. Aflatoxin B1-induced hepatocellular carcinoma in developing countries: geographical distribution, mechanism of action and prevention. Oncol Lett. 2013;5:1087\u201392.","journal-title":"Oncol Lett"},{"key":"1740_CR119","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1038\/sj.onc.1208732","volume":"24","author":"GD Kirk","year":"2005","unstructured":"Kirk GD, Lesi OA, Mendy M, et al. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene. 2005;24:5858\u201367.","journal-title":"Oncogene"},{"key":"1740_CR120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1478-3231.2003.00869.x","volume":"23","author":"MC Kew","year":"2003","unstructured":"Kew MC. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int. 2003;23:405\u20139.","journal-title":"Liver Int"},{"key":"1740_CR121","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.VMBF-0030-2016","author":"DL Allison","year":"2016","unstructured":"Allison DL, Willems HME, Jayatilake J, et al. Candida-bacteria interactions: their impact on human disease. Microbiol Spectr. 2016;. https:\/\/doi.org\/10.1128\/microbiolspec.VMBF-0030-2016.","journal-title":"Microbiol Spectr."},{"key":"1740_CR122","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4161\/gmic.26040","volume":"4","author":"DA Garsin","year":"2013","unstructured":"Garsin DA, Lorenz MC. Candida albicans and Enterococcus faecalis in the gut: synergy in commensalism? Gut Microbes. 2013;4:409\u201315.","journal-title":"Gut Microbes"},{"key":"1740_CR123","first-page":"497","volume":"9","author":"L Markey","year":"2018","unstructured":"Markey L, Shaban L, Green ER, et al. Pre-colonization with the commensal fungus Candida albicans reduces murine susceptibility to Clostridium difficile infection. Gut Microbes. 2018;9:497\u2013509.","journal-title":"Gut Microbes"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01740-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-020-01740-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01740-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T16:46:09Z","timestamp":1611247569000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-020-01740-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1740"],"URL":"https:\/\/doi.org\/10.1007\/s00535-020-01740-5","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"assertion":[{"value":"27 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"B.S. has been consulting for Ferring Research Institute, HOST Therabiomics, Intercept Pharmaceuticals, Mabwell Therapeutics, and Patara Pharmaceuticals. B.S.\u2019s institution UC San Diego has received grant support from Axial Biotherapeutics, BiomX, CymaBay Therapeutics, NGM Biopharmaceuticals, and Synlogic Operating Company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}